Difficulty: Medium
Average Score: 81%
Practice
The following agents are cardioselective beta1-adrenoceptor-blocking drugs labeled for use in angina, EXCEPT:
Correct answer
D
Rationale
In pharmacology, understanding the differences between beta-adrenoceptor-blocking drugs is crucial for safe and effective patient care. In the context of angina, cardioselective beta1-adrenoceptor-blocking drugs are preferred as they primarily target the beta1 receptors in the heart, reducing the heart rate and contractility without affecting beta2 receptors found in the lungs.
The correct answer is D) Propranolol because it is a non-selective beta-blocker, meaning it blocks both beta1 and beta2 receptors. This can lead to unwanted side effects such as bronchoconstriction in patients with respiratory conditions.
A) Metoprolol, B) Talinolol, and C) Atenolol are cardioselective beta1-adrenoceptor-blocking drugs specifically indicated for angina. Metoprolol and Atenolol are commonly prescribed for various cardiovascular conditions due to their cardioselectivity and favorable side effect profiles.
Educationally, knowing the selectivity of beta-blockers is essential for tailoring treatment to individual patients. Understanding the pharmacological properties of each drug helps healthcare providers make informed decisions to optimize therapy and minimize adverse effects, ultimately improving patient outcomes.
The correct answer is D) Propranolol because it is a non-selective beta-blocker, meaning it blocks both beta1 and beta2 receptors. This can lead to unwanted side effects such as bronchoconstriction in patients with respiratory conditions.
A) Metoprolol, B) Talinolol, and C) Atenolol are cardioselective beta1-adrenoceptor-blocking drugs specifically indicated for angina. Metoprolol and Atenolol are commonly prescribed for various cardiovascular conditions due to their cardioselectivity and favorable side effect profiles.
Educationally, knowing the selectivity of beta-blockers is essential for tailoring treatment to individual patients. Understanding the pharmacological properties of each drug helps healthcare providers make informed decisions to optimize therapy and minimize adverse effects, ultimately improving patient outcomes.